Selected Publications

Thieu VT, Robinson S, Kennedy-Martin T, Boye KS, Garcia-Perez LE. Patient preferences for glucagon-like peptide 1 receptor-agonist treatment attributes. Patient Prefer Adherence. 2019 Apr 17;13:561-576

Blaiss MS, Hammerby E, Robinson S, Kennedy-Martin T, Buchs S. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review. Ann Allergy Asthma Immunol. 2018 Apr 4.

Kennedy-Martin T, Bae JP, Paczkowski R, Freeman E. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review. J Patient Rep Outcomes. 2018 Jun 19;2:28.

Kennedy-Martin T, Boye KS, Peng X. Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Prefer Adherence. 2017 Jun 30;11:1103-1117.

Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015 Nov 3;16:495.

Kennedy-Martin T, Paczkowski R, Rayner S. Utility values in diabetic kidney disease: a literature review. Curr Med Res Opin. 2015;31(7):1271-82.

Paczkowski R, Norrbacka K, Van BK, Kennedy-Martin T. A Review Of Cost Of Illness Studies In Patients With End Stage Renal Disease. Value Health. 2014 Nov;17(7):A468.

Paczkowski R, Kennedy-Martin T, Rayner S. A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic Nephropathy. Value Health. 2014 Nov;17(7):A550-1.

Kennedy-Martin T, Mitchell B, Boye KS, Chen W, Curtis B, Flynn J, Ikeda S, Liu L, Tarn T, Yang BM.  The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies.  Value in Health Regional Issues 2014, Volume 3, Pages 108-116.

Knight C, Danø AM, Kennedy-Martin T. A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.  Haemophilia. 2009 Mar;15(2):405-19. Epub 2009 Feb 1.

Knight C, Danø AM, Kennedy-Martin T. Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors.. Adv Ther. 2009 Jan;26(1):68-88. Epub 2009 Jan 20.

Nafees B, Lloyd A, Kennedy-Martin T, Hynd S. How diabetes and insulin therapy affects the lives of people with type 1 diabetes. EDN Summer 2006, Vol 3, No. 2.

Lee A, Morgan C, Morrissey M, Wittrup-Jensen K, Kennedy-Martin T and Currie C. Evaluation of the association between the EQ-5D index (health-related utility) and body mass index (obesity) in hospital treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes Diabet Med. 2005 Nov;22(11):1482-6.

Woodcock A, Plowright R, Kennedy-Martin T, Hirsch A, ffytche T, Bradley C (2005).  Development of the new Retinopathy Treatment Satisfaction Questionnaire (RetTSQ).  Proceedings of Vision 2005; International Congress Series. 1282, 342-346

Davis R, Morrissey M, Peters J, Wittrup-Jensen K, Kennedy-Martin T, Currie C. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Current Medical Research and Opinion, Vol 21, No 9, 2005: 1477-1483

Coyne KS, Margolis MK, Kennedy-Martin T, Baker TM, Klein R, Paul MD, Revicki DA. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract. 2004 Aug;21(4):447-53.

Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye. 2004 Oct;18(10):963-83.

Woodcock A, Bradley C, Plowright R, Ffytche T, Kennedy-Martin T, Hirsch A. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Couns. 2004 Jun;53(3):365-83.

Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O, Revicki DA. Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics. 2002;20(12):791-812.

Scuffham P, Legood R, Wilson E, Kennedy-Martin T. The incidence and cost of injurious falls associated with visual impairment in the UK. Visual Impairment Research 2002. Vol 4, No 1, pp 1-44

Sacristan JA, Kennedy-Martin T, Rosell R, Cardenal F, Anton A, Lomas M, Alberola V, Massuti B, Carrato A, Minshall M. Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. Lung Cancer. 2000 May;28(2):97-107.

Duthie T, Trueman P, Chancellor J, Diez L. Research into the use of health economics in decision making in the United Kingdom-Phase II. Is health economics ‘for good or evil’? Health Policy. 1999 Jan;46(2):143-57.

Jackson D, Duthie T. If comparisons can be odious, so can assumptions. Seizure. 1996 Sep;5(3):247-8.

Gross MLP, Dowson AJ, Deavy L, Duthie T (1996) Impact of oral sumatriptan 50 mg on work productivity and quality of life in migraineurs. Br J Med Economics 10: 231-246